Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Surgery Partners (SGRY) Long-Term Debt Issuances (2016 - 2025)

Surgery Partners' Long-Term Debt Issuances history spans 12 years, with the latest figure at $692.5 million for Q4 2025.

  • For Q4 2025, Long-Term Debt Issuances rose 160.44% year-over-year to $692.5 million; the TTM value through Dec 2025 reached $1.2 billion, down 30.47%, while the annual FY2025 figure was $1.2 billion, 30.47% down from the prior year.
  • Long-Term Debt Issuances for Q4 2025 was $692.5 million at Surgery Partners, up from $127.9 million in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $1.1 billion in Q2 2024 and bottomed at $500000.0 in Q2 2022.
  • The 5-year median for Long-Term Debt Issuances is $147.2 million (2022), against an average of $213.8 million.
  • The largest annual shift saw Long-Term Debt Issuances tumbled 99.82% in 2022 before it surged 10304.72% in 2024.
  • A 5-year view of Long-Term Debt Issuances shows it stood at $6.4 million in 2021, then soared by 2503.12% to $166.6 million in 2022, then soared by 324.49% to $707.2 million in 2023, then crashed by 62.4% to $265.9 million in 2024, then soared by 160.44% to $692.5 million in 2025.
  • Per Business Quant, the three most recent readings for SGRY's Long-Term Debt Issuances are $692.5 million (Q4 2025), $127.9 million (Q3 2025), and $168.6 million (Q2 2025).